Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 3, 2003

View Archived Issues

Effective control of plaque psoriasis achieved with continuous efalizumab

Antitumor effects of irofulven in advanced cancer

Clinical trials confirm the good safety profile of anecorvate acetate

Radiosensitizing effects of GW-572016 and use in combination chemotherapy

Preclinical and clinical antitumor efficacy and clinical safety of Bay-43-9006

R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: Rejuvenon

Beneficial effects of SKI-606 in rat models of stroke

Antiproliferative and cytotoxic effects of aplidine assessed in human cancer cell lines

In vitro efficacy of 2-methoxyestradiol in prostate and pancreatic cancer

New CRF1 antagonists with utility in anxiety and depression

BMS researchers describe new p38 kinase inhibitors and their therapeutic use

New anxiolytic agents prepared and tested by Egis researchers

Roche claims novel alpha1A-adrenoceptor agonists for urinary incontinence and other uses

Novel IBAT inhibitors identified at AstraZeneca

New antibacterial agents described by the former British Biotech (now Vernalis)

Fast track designation for TheraCLEC

Melanotan reduces sunburn injury by increasing melanin density in clinical trial

Celltech to regain rights to CDP-870 from Pfizer

Ganymed acquires ImmuGenics, inlicenses TCR intellectual property

FDA accepts Avastin BLA for priority review

First approval for Erbitux granted by Swiss authorities

IsoTis OrthoBiologics establishes EpiSource subsidiary for wound care portfolio

Neurogen and Merck & Co. target vanilloid receptor through new alliance

Keppra reduces seizures in epileptic patients with brain tumors

P2Y1 receptor antagonists with enhanced potency designed by U.S.-Korean group

R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: Xantos Biomedicine

Antiparkinsonian and antidyskinesia effects of GR-127935, a 5-HT1B/1D receptor antagonist

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...